GST 2.0 Slashes Prices of Critical Medicines—A Boost for Cancer and Chronic Illness Patients
New Delhi, September 4, 2025 — The government’s updated GST regime, dubbed GST 2.0, introduces sweeping tax reliefs for life-saving drugs and chronic disease medications. A total of 33 essential medicines will now be fully exempt from GST, while many others will see a drop to 5%—a major step toward making healthcare more accessible. (Source: Times of India)
Key Highlights of the Reform
- **Full exemption** for 33 critical medicines treating cancer, rare diseases, and severe chronic conditions.
- GST on most other approved medicines, diagnostic kits, and health/life insurance policies cut from **12% to 5%**, reducing financial burden.
- Policy aims to transform affordability, particularly for households managing long-term health expenses.
Why It Matters
This reform brings tangible relief to patients facing high medical costs. Especially impactful for families managing chronic illnesses and cancer, the reduced taxes mean direct and sustained benefits.
Expected Impact
- Lower out-of-pocket expenses for treatment and medical supplies.
- A potential rise in insurance uptake due to lower premiums.
- Greater healthcare inclusivity across socio-economic groups.
Source: Times of India (Read Original)
Labels: GST Reform, Healthcare Relief, Cancer Treatment, Chronic Diseases, Government Policy
Tags: #HealthcareForAll #GST2.0 #MedicineAffordability #IndiaHealthcare
Disclaimer: This article is based on reporting by the Times of India. Jammu News Portal does not assume responsibility for the accuracy of external sources.
Post a Comment